Orchid Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ORCHPHARMA BSE: 524372

About Orchid Pharma Limited

Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug (NCE) Enmetazobactam which is now approved in United States, Europe and India.

Source: Wikipedia

Key facts

BSE symbol524372
NSE symbolORCHPHARMA
ISININE191A01027
CINL24222TN1992PLC022994
Listing date2 Nov 2020
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorS Dhanapal & Associates LLP (Ramanathan Nachiappan)
Registered officePlot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Chengalpattu District- 603110, Tamil Nadu

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)867†—850†685†566†
Net profit45†1069554—

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Manish DhanukaExecutive DirectorJune 30, 2026
Mridul DhanukaExecutive DirectorJune 30, 2026
Dharam VirIndependent DirectorJune 30, 2026
Manoj Kumar GoyalIndependent DirectorJune 30, 2026
Shubha SinghIndependent DirectorJune 30, 2026
Tanu SinglaIndependent DirectorJune 30, 2026
Arjun DhanukaNon-Executive DirectorJune 30, 2026
Ram Gopal AgarwalNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.